A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.

BMC Neurol · 2011 · PMC3170595 · PMID 21819556

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

showed a trendp = 0.078so close (0.05 < p ≤ 0.1)

Months 11, 13 and 14 showed a trend (p = 0.078) towards lower doses of prednisone in the MTX-group (Figure 2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.